By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


T2 Biosystems 

101 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-457-1200 Fax: 781-357-3080



Company News
Diagnostics Developer T2 Biosystems Files For A $69 Million IPO 7/3/2014 7:39:07 AM
T2 Biosystems Release: Clinical Chemistry Study Reports On Use Of T2MR To Evaluate Hemostasis In Whole Blood 6/23/2014 11:08:27 AM
T2 Biosystems Submits 510(K) Application To The FDA For Review Of T2Dx And T2Candida 6/3/2014 9:52:28 AM
T2 Biosystems Presents New Data At The Thrombosis And Hemostasis Summit Of North America Demonstrating Ability Of T2MR Platform Technology To Measure Platelet Activity And Additional Hemostasis Parameters 4/10/2014 7:31:28 AM
T2 Biosystems Appoints Michael Pfaller, MD, Chief Medical Officer 4/3/2014 2:27:15 PM
T2 Biosystems Awarded Top Honor As ‘Most Promising Company’ At Personalized Medicine World Conference 2014 1/30/2014 9:14:27 AM
T2HemoStat Detection Of Novel Clot Behavior Could Direct Therapeutic Choices For Stroke And Heart Attack Victims, T2 Biosystems Reveals 1/14/2014 6:24:20 AM
T2 Biosystems And Collaborators Announce Discovery Of Novel Clot Structure Biology Enabled By T2hemostat™ 1/9/2014 10:52:26 AM
T2 Biosystems To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/6/2014 8:05:08 AM
T2 Biosystems Strengthens Management Team As Company Prepares For Launch Of Flagship T2Candida™ Diagnostic Test 12/11/2013 9:27:22 AM